Thiamin Against Robust IBD Fatigue
NCT03634735 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2020-10-29
Summary
Patients with Inflammatory Bowel Disease (IBD), disease in remission and chronic fatigue will receive oral Thiamine treatment for 4 weeks in a RCT, cross-over study.
Conditions
Interventions
- DRUG
-
Thiamine
Vitamine B1
- OTHER
-
Placebo
Placebo tablets
Sponsors & Collaborators
-
University of Aarhus
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-11-27
- Primary Completion
- 2020-04-21
- Completion
- 2020-10-27
Countries
- Denmark
Study Locations
More Related Trials
-
GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis
NCT00457171 ·Status: TERMINATED ·Phase: PHASE1
-
Vitamin D Repletion and Maintenance in IBD: How Much and How Often
NCT03053414 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease
NCT03870334 ·Status: TERMINATED ·Phase: PHASE2
-
High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade
NCT03162432 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
5-HTP in Patients With IBD in Clinical and Biologic Remission:Effect on Fatigue Scores
NCT03574948 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease
NCT03599622 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis
NCT00385736 ·Status: COMPLETED ·Phase: PHASE3
-
Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)
NCT03943550 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT04033445 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
NCT01453491 ·Status: COMPLETED ·Phase: PHASE1
-
L-carnitine to Treat Fatigue Associated With Crohn's Disease
NCT01523106 ·Status: WITHDRAWN ·Phase: NA
-
Impact of Additional Treatment With Saccharomyces Boulardii on Quality of Life in Patients With Mild Forms of Ulcerative Colitis and Crohn Disease
NCT03941418 ·Status: UNKNOWN ·Phase: NA
-
Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease
NCT03266484 ·Status: COMPLETED ·Phase: NA
-
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
NCT01294410 ·Status: COMPLETED ·Phase: PHASE2
-
Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC)
NCT00746447 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
NCT06979336 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
NCT02435992 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis
NCT01039597 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease
NCT00106314 ·Status: COMPLETED ·Phase: PHASE2
-
Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis
NCT05225545 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis
NCT03235752 ·Status: COMPLETED ·Phase: PHASE2
-
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
NCT01466374 ·Status: COMPLETED ·Phase: PHASE2
-
Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease
NCT00234741 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Microscopic Colitis
NCT00184171 ·Status: TERMINATED ·Phase: NA
-
The Effect of Riboflavin in Crohn's Disease
NCT02538354 ·Status: COMPLETED ·Phase: NA